Skip to main content

Viracta Therapeutics, Inc.

VIRXDelisted Jul 10, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001061027

Viracta Therapeutics, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Nov 27, 2024; 32 institutions reported holding it in 13F filings for Q4 2024, worth $583.0K in total; no superinvestor held it.

13F holders, Q1 2024

Institutional positions in Viracta Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
40
−2 vs. Q4 2023
Shares held
9.39M
−357.8K (−3.7%) vs. Q4 2023
Total value
$9.58M
+$4.02M (+72.4%) vs. Q4 2023
New holders
4
9 more added
Sold out
6
6 more reduced

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VIRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 40 institutions
Q1 2021: 50 institutionsQ2 2021: 63 institutionsQ3 2021: 68 institutionsQ4 2021: 69 institutionsQ1 2022: 69 institutionsQ2 2022: 63 institutionsQ3 2022: 59 institutionsQ4 2022: 56 institutionsQ1 2023: 48 institutionsQ2 2023: 41 institutionsQ3 2023: 42 institutionsQ4 2023: 42 institutionsQ1 2024: 40 institutionsQ2 2024: 40 institutionsQ3 2024: 38 institutionsQ4 2024: 32 institutionsQ1 2025: 7 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 1 institutionQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2024: $9.58M
Q1 2021: $92.0MQ2 2021: $151.8MQ3 2021: $124.6MQ4 2021: $51.8MQ1 2022: $62.2MQ2 2022: $44.2MQ3 2022: $52.8MQ4 2022: $18.1MQ1 2023: $19.4MQ2 2023: $14.1MQ3 2023: $10.1MQ4 2023: $5.56MQ1 2024: $9.58MQ2 2024: $4.91MQ3 2024: $1.29MQ4 2024: $583.0KQ1 2025: $3.80KQ2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding VIRX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20251$0
Q3 20250$0
Q2 20250$0
Q1 20257$3.80K
Q4 202432$583.0K
Q3 202438$1.29M
Q2 202440$4.91M
Q1 202440$9.58M
Q4 202342$5.56M
Q3 202342$10.1M
Q2 202341$14.1M
Q1 202348$19.4M
Q4 202256$18.1M
Q3 202259$52.8M
Q2 202263$44.2M
Q1 202269$62.2M
Q4 202169$51.8M
Q3 202168$124.6M
Q2 202163$151.8M
Q1 202150$92.0M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Viracta Therapeutics, Inc.; share changes are against Q4 2023.

Institutions holding VIRX in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Qube Research & Technologies Ltd2$20.00%00.0%Unchanged
Addison Advisors LLC4$50.00%00.0%Unchanged
Parallel Advisors, LLC8$80.00%00.0%Unchanged
GWM Advisors LLC14$140.00%00.0%Unchanged
UBS Group AG95$970.00%−168,573−99.9%Reduced
Indiana Trust & Investment Management CO200$2040.00%00.0%Unchanged
Wells Fargo & Company385$3920.00%+3+0.8%Added
JPMorgan Chase & Co721$7350.00%00.0%Unchanged
NBC Securities, Inc.1,400$1.00K0.00%+1,400New
Royal Bank of Canada2,068$2.00K0.00%−8,437−80.3%Reduced
Barclays PLC2,668$2.72K0.00%00.0%Unchanged
IAG Wealth Partners, LLC3,000$3.06K0.00%00.0%Unchanged
RP Management, LLC3,700$3.77K0.00%00.0%Unchanged
Simplex Trading, LLC4,884$4.00K0.00%+4,884New
Planning Capital Management Corp7,272$7.42K0.01%00.0%Unchanged
Tower Research Capital LLC (TRC)8,889$9.07K0.00%−5,109−36.5%Reduced
Acadian Asset Management LLC10,908$11.0K0.00%−53,782−83.1%Reduced
WealthTrust Axiom LLC11,396$11.6K0.00%+11,396New
Bank of America Corp12,271$12.5K0.00%+4,207+52.2%Added
Trust Co of Toledo NA12,317$12.6K0.00%00.0%Unchanged
Hoylecohen, LLC14,000$14.3K0.00%00.0%Unchanged
Inspirion Wealth Advisors, LLC15,000$15.3K0.00%+5,000+50.0%Added
XTX Topco Ltd16,988$17.3K0.00%+5,237+44.6%Added
Beacon Pointe Advisors, LLC17,500$17.9K0.00%+17,500New
United Bank25,200$25.7K0.00%00.0%Unchanged
Northern Trust Corp38,190$39.0K0.00%+1,729+4.7%Added
Ensign Peak Advisors, Inc63,406$64.7K0.00%00.0%Unchanged
State Street Corp65,867$67.2K0.00%00.0%Unchanged
Bridgeway Capital Management, LLC74,000$75.5K0.00%00.0%Unchanged
Morgan Stanley118,016$120.4K0.00%+30,675+35.1%Added
Renaissance Technologies LLC202,499$207.0K0.00%+23,600+13.2%Added
Geode Capital Management, LLC252,701$257.8K0.00%00.0%Unchanged
Aisling Capital Management LP288,571$294.3K0.10%00.0%Unchanged
BlackRock Inc.303,980$310.1K0.00%−1,672−0.5%Reduced
MAI Capital Management364,097$371.4K0.00%+8,637+2.4%Added
Laurion Capital Management LP420,426$428.8K0.01%−142,569−25.3%Reduced
Samsara BioCapital, LLC689,709$703.5K0.11%00.0%Unchanged
Vanguard Group Inc1,161,280$1.18M0.00%00.0%Unchanged
Citadel Advisors LLC1,565,202$1.60M0.00%+36,130+2.4%Added
BVF Inc3,614,662$3.69M0.10%00.0%Unchanged
Susquehanna International Group, LLP0$00.00%−41,412−100.0%Sold out
Squarepoint Ops LLC0$00.00%−36,098−100.0%Sold out
Virtu Financial LLC0$00.00%−27,378−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−15,634−100.0%Sold out
Bourgeon Capital Management LLC0$00.00%−7,500−100.0%Sold out
Private Ocean, LLC0$00.00%−3−100.0%Sold out